JBT Marel (JBTM) is an interesting investment opportunity, given its unique combination of secular growth, high margin recurring revenue, and robust free cash flow generation, Oppenheimer said in a Thursday report.

The company's protein segment is a leader in protein processing equipment, while its prepared foods business holds top market positions in downstream value-added preparation, preservation, and packaging of ready-to-eat foods, the Oppenheimer analysts said.

JBT Marel appears positioned to outgrow the market by 200 to 300 basis points and deliver an organic revenue compound annual growth rate of 5% to 7% from fiscal 2025 through 2028, driven by revenue synergies and growth initiatives, according to the report.

Oppenheimer initiated coverage of JBT Marel with an outperform rating and a $175 price target.

Price: 128.78, Change: +0.07, Percent Change: +0.05